drugset
drugset / Trial / NCT00482417

Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)

NCT00482417 ↗

Phase 2 Completed 11 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

Efficacy and Safety Study of MK0359 in Patients with Arthritis

Timeline

Start
2002-12
Primary completion
2003-05
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Subject MK0359 Unknown — —

Indications

rheumatoid arthritis